{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:17:06Z","timestamp":1790032626601,"version":"4.0.1"},"reference-count":33,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/mmr.2014.2211","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T08:40:06Z","timestamp":1399365606000},"page":"567-571","source":"Crossref","is-referenced-by-count":6,"title":["Preparation and characterization of luteinising-hormone releasing hormone nanoliposomal microbubbles specifically targeting ovarian cancer cells in vitro"],"prefix":"10.3892","volume":"10","author":[{"given":"JINYI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SISUN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUANFANG","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIPING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENJUAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FEN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUYING","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"key20180108011018_b1-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20180108011018_b2-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2741\/4119","article-title":"Ovarian cancer as a genetic disease","volume":"18","author":"Lech","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"Suppl 1","key":"key20180108011018_b3-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/IGC.0b013e318251c97d","article-title":"Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers","volume":"22","author":"Bast","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108011018_b4-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.clinbiochem.2013.03.010","article-title":"Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients","volume":"46","author":"Leung","year":"2013","journal-title":"Clin Biochem"},{"key":"key20180108011018_b5-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3390\/ijms14036026","article-title":"HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines","volume":"14","author":"Li","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180108011018_b6-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J Clin Pathol"},{"key":"key20180108011018_b7-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-013-2722-2","article-title":"Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?","volume":"288","author":"Azzam","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"key20180108011018_b8-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1515\/CCLM.2011.709","article-title":"The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses","volume":"49","author":"Lenhard","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"key20180108011018_b9-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","article-title":"Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response","volume":"8","author":"Hamed","year":"2013","journal-title":"Diagn Pathol"},{"key":"key20180108011018_b10-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/ijms14010640","article-title":"Ovarian cancer: in search of better marker systems based on DNA repair defects","volume":"14","author":"Varga","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180108011018_b11-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1525-1438.2007.01064.x","article-title":"Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer","volume":"18","author":"Arits","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108011018_b12-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1148\/radiol.10101079","article-title":"Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging","volume":"258","author":"Deshpande","year":"2011","journal-title":"Radiology"},{"key":"key20180108011018_b13-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2967\/jnumed.109.068007","article-title":"Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides","volume":"51","author":"Willmann","year":"2010","journal-title":"J Nucl Med"},{"key":"key20180108011018_b14-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7863\/jum.2010.29.2.173","article-title":"Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer","volume":"29","author":"Barua","year":"2010","journal-title":"J Ultrasound Med"},{"key":"key20180108011018_b15-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"145607","DOI":"10.1088\/0957-4484\/21\/14\/145607","article-title":"The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging","volume":"21","author":"Xing","year":"2010","journal-title":"Nanotechnology"},{"key":"key20180108011018_b16-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1134\/S1063771009040162","article-title":"Application of Ultrasound for Targeted Nanotherapy of Malignant Tumors","volume":"55","author":"Rapoport","year":"2009","journal-title":"Acoust Phys"},{"key":"key20180108011018_b17-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/mp9001816","article-title":"Formulation and characterization of echogenic lipid-Pluronic nanobubbles","volume":"7","author":"Krupka","year":"2010","journal-title":"Mol Pharm"},{"key":"key20180108011018_b18-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0169-409X(02)00044-3","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"54","author":"Brigger","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"key20180108011018_b19-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/RLI.0b013e3182034fed","article-title":"Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent","volume":"46","author":"Anderson","year":"2011","journal-title":"Invest Radiol"},{"key":"key20180108011018_b20-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7863\/jum.2010.29.4.609","article-title":"Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells: feasibility research for ultrasonic molecular imaging of tumor cells","volume":"29","author":"Xing","year":"2010","journal-title":"J Ultrasound Med"},{"key":"key20180108011018_b21-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mob.2002.119633","article-title":"Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues","volume":"186","author":"V\u00f6lker","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108011018_b22-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00404-012-2335-1","article-title":"Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH)","volume":"286","author":"Engel","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key20180108011018_b23-mmr-10-01-0567","first-page":"895","article-title":"Nanobubbles for enhanced ultrasound imaging of tumors","volume":"7","author":"Yin","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"key20180108011018_b24-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1166\/jnn.2007.645","article-title":"Biological and chemical decoration of peptide nanostructures via biotin-avidin interactions","volume":"7","author":"Reches","year":"2007","journal-title":"J Nanosci Nanotechnol"},{"key":"key20180108011018_b25-mmr-10-01-0567","first-page":"143","article-title":"Avidin-biotin technology: preparation of avidin conjugates","volume":"10","author":"Bayer","year":"1992","journal-title":"Methods Mol Biol"},{"key":"key20180108011018_b26-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ultras.2003.11.011","article-title":"Development and characterization of a nano-scale contrast agent","volume":"42","author":"Oeffinger","year":"2004","journal-title":"Ultrasonics"},{"key":"key20180108011018_b27-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/cvr\/cvt102","article-title":"The use of shear stress for targeted drug delivery","volume":"99","author":"Saxer","year":"2013","journal-title":"Cardiovasc Res"},{"key":"key20180108011018_b28-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10404-012-1024-5","article-title":"The influence of size, shape and vessel geometry on nanoparticle distribution","volume":"14","author":"Tan","year":"2013","journal-title":"Microfluid Nanofluidics"},{"key":"key20180108011018_b29-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.biomaterials.2009.11.044","article-title":"The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent","volume":"31","author":"Diaz-L\u00f3pez","year":"2010","journal-title":"Biomaterials"},{"key":"key20180108011018_b30-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj3160193","article-title":"Reversibility of biotin-binding by selective modification of tyrosine in avidin","volume":"316","author":"Morag","year":"1996","journal-title":"Biochem J"},{"key":"key20180108011018_b31-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/02652048.2011.638993","article-title":"Development and evaluation of lipid microbubbles targeted to alpha(v)beta(3)-integrin via biotin-avidin bridge","volume":"29","author":"Wang","year":"2012","journal-title":"J Microencapsul"},{"key":"key20180108011018_b32-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/bc049898y","article-title":"Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging","volume":"16","author":"Klibanov","year":"2005","journal-title":"Bioconjug Chem"},{"key":"key20180108011018_b33-mmr-10-01-0567","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.nuclcard.2007.09.008","article-title":"Ultrasound molecular imaging with targeted microbubble contrast agents","volume":"14","author":"Klibanov","year":"2007","journal-title":"J Nucl Cardiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2211\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:45:29Z","timestamp":1515361529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,6]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/mmr.2014.2211"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2211","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]}}}